全文获取类型
收费全文 | 897篇 |
免费 | 65篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 41篇 |
妇产科学 | 5篇 |
基础医学 | 100篇 |
口腔科学 | 44篇 |
临床医学 | 75篇 |
内科学 | 194篇 |
皮肤病学 | 40篇 |
神经病学 | 62篇 |
特种医学 | 149篇 |
外国民族医学 | 1篇 |
外科学 | 67篇 |
综合类 | 39篇 |
预防医学 | 67篇 |
眼科学 | 5篇 |
药学 | 47篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2022年 | 3篇 |
2021年 | 3篇 |
2020年 | 4篇 |
2019年 | 9篇 |
2018年 | 10篇 |
2017年 | 18篇 |
2016年 | 19篇 |
2015年 | 30篇 |
2014年 | 17篇 |
2013年 | 37篇 |
2012年 | 30篇 |
2011年 | 32篇 |
2010年 | 31篇 |
2009年 | 48篇 |
2008年 | 29篇 |
2007年 | 21篇 |
2006年 | 17篇 |
2005年 | 18篇 |
2004年 | 33篇 |
2003年 | 16篇 |
2002年 | 15篇 |
2001年 | 8篇 |
2000年 | 7篇 |
1999年 | 18篇 |
1998年 | 54篇 |
1997年 | 63篇 |
1996年 | 57篇 |
1995年 | 42篇 |
1994年 | 40篇 |
1993年 | 37篇 |
1992年 | 8篇 |
1991年 | 11篇 |
1990年 | 16篇 |
1989年 | 15篇 |
1988年 | 22篇 |
1987年 | 23篇 |
1986年 | 21篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1983年 | 8篇 |
1982年 | 18篇 |
1981年 | 3篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1975年 | 2篇 |
1968年 | 3篇 |
1959年 | 2篇 |
排序方式: 共有971条查询结果,搜索用时 15 毫秒
961.
Kanal E Barkovich AJ Bell C Borgstede JP Bradley WG Froelich JW Gilk T Gimbel JR Gosbee J Kuhni-Kaminski E Lester JW Nyenhuis J Parag Y Schaefer DJ Sebek-Scoumis EA Weinreb J Zaremba LA Wilcox P Lucey L Sass N;ACR Blue Ribbon Panel on MR Safety 《AJR. American journal of roentgenology》2007,188(6):1447-1474
962.
963.
964.
Antinarelli LM Carmo AM Pavan FR Leite CQ Da Silva AD Coimbra ES Salunke DB 《Organic and medicinal chemistry letters》2012,2(1):16
ABSTRACT: BACKGROUND: Aminoquinoline/steroid conjugates were synthesized based on the fact that steroid transporters have been shown to accept and carry a variety of drugs. So, in continuing our research of antileishmanial and antitubercular drugs, aminoquinoline/steroid conjugates (12, 13, and 14) were regioselectively synthesized via 1,3-dipolar cycloaddition of alkynes 3, 5, and 7 with azide 12. The aminoquinoline/steroids conjugates were evaluated in vitro against Leishmania major and Mycobacterium tuberculosis. RESULTS: The regioselective synthesis of the novel aminoquinoline/steroid conjugates was achieved in very high yield. All aminoquinoline/steroid conjugates (12, 13, and 14) exhibited best results against Leishmania and M. tuberculosis than the respective alkyne intermediate structures (3, 5, and 7, respectively). Among them, the compound 12 exhibited the best activity for M. tuberculosis (MIC = 8.8 uM). This result is comparable to drugs commonly used in tuberculosis treatment. Also, for antileishmanial assay, the aminoquinoline/steroid conjugates demonstrated a significant activity against promastigote and amastigote forms of L. major. These results highlight the importance of steroids as carrier. KEYWORDS: antileishmanial drugs; antituberculosis drugs; click chemistry; quinoline; steroid. 相似文献
965.
Cécilia Samieri Catherine Féart Cécile Proust-Lima Evelyne Peuchant Jean-François Dartigues Hélène Amieva Pascale Barberger-Gateau 《Neurobiology of aging》2011,32(12):2317
Long-chain omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may slow cognitive decline. The ε4 allele of the ApolipoproteinE (ApoE), the main genetic risk factor for Alzheimer's disease, and depressive symptoms, which are frequently associated with cognitive impairment in older persons, may modify this relationship. We estimated the associations between EPA and DHA plasma levels and subsequent cognitive decline over 7 years, taking into account ApoE-ε4 status and depressive symptoms, in a prospective population-based cohort. Participants (≥ 65 years, n = 1,228 nondemented at baseline) were evaluated at least once over three follow-up visits using four cognitive tests. Plasma EPA was associated with slower decline on Benton Visual Retention Test (BVRT) performances in ApoE-ε4 carriers, or in subjects with high depressive symptoms at baseline. Plasma DHA was associated with slower decline on BVRT performances in ApoE-ε4 carriers only. EPA and DHA may contribute to delaying decline in visual working memory in ApoE-ε4 carriers. In older depressed subjects, EPA, but not DHA, may slow cognitive decline. 相似文献
966.
Gorlov IP, Gorlova OY, Frazier ML, Spitz MR, Amos CI. Evolutionary evidence of the effect of rare variants on disease etiology. The common disease/common variant hypothesis has been popular for describing the genetic architecture of common human diseases for several years. According to the originally stated hypothesis, one or a few common genetic variants with a large effect size control the risk of common diseases. A growing body of evidence, however, suggests that rare single‐nucleotide polymorphisms (SNPs), i.e. those with a minor allele frequency of less than 5%, are also an important component of the genetic architecture of common human diseases. In this study, we analyzed the relevance of rare SNPs to the risk of common diseases from an evolutionary perspective and found that rare SNPs are more likely than common SNPs to be functional and tend to have a stronger effect size than do common SNPs. This observation, and the fact that most of the SNPs in the human genome are rare, suggests that rare SNPs are a crucial element of the genetic architecture of common human diseases. We propose that the next generation of genomic studies should focus on analyzing rare SNPs. Further, targeting patients with a family history of the disease, an extreme phenotype, or early disease onset may facilitate the detection of risk‐associated rare SNPs. 相似文献
967.
968.
A variant of von Willebrand disease (vWD) was identified in six members of a kindred spanning four generations. The proband was a 46-year-old woman with a lifelong history of bleeding, a prolonged bleeding time (> 15 minutes), markedly elevated von Willebrand factor (vWF) antigen (vWF:Ag = 2.09 U/mL), slightly reduced ristocetin cofactor activity, and a plasma vWF multimer pattern similar to that of vWD type IIC. Similar findings were observed in her three children, mother, and brother. In affected family members, platelet and plasma vWF multimer patterns were discrepant with higher molecular weight multimers observed in platelet vWF. Following a 1-Des-amino-8-D-arginine vasopressin (DDAVP) challenge, the proband failed to normalize her bleeding time even though vWF: Ag rose by 70% and higher molecular weight multimers were increased slightly. Genetic studies were consistent with autosomal dominant inheritance of a mutation within the vWF gene. By sequencing of cloned genomic DNA, mutations were excluded in exons 4, 5, 14, and 15, which encode regions of the vWF propeptide proposed to be important in multimer biosynthesis. Mutations also were excluded in exons 28 to 31, which encompass the known mutations that cause vWD types IIA, IIB, and B. This new variant of vWD, characterized by autosomal dominant inheritance, a qualitative defect that resembles vWD type IIC, and increased plasma vWF:Ag, was tentatively designated vWD type IIC Miami. 相似文献
969.
MR Dr. Dr. Gerhard Kreyer 《Stomatologie》2015,112(1-2):29-34
970.
MR DDr. Hannes Gruber 《Stomatologie》2015,112(6):207-207